GlassScriptPhysician profile
John Katopodis
NPI 1477559623
$11,188.91
in general payments reported to CMS, 2019-2025
37 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,545 · 2020: $1,561 · 2021: $1,469 · 2022: $1,001 · 2023: $788 · 2024: $1,260 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,497 · Travel and Lodging: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,496.92 |
| Travel and Lodging | $114.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $2,145.38 | 2019-2022 | |
| Abiomed | $1,407.27 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,076.33 | 2019-2025 | Avvigo Guidance System, General - Angioplasty, Ffr Link |
| Shockwave Medical, INC | $1,005.04 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $921.75 | 2019-2024 | Mitraclip, Diamondback Coronary, Diamondback Peripheral |
| Medtronic, INC. | $845.13 | 2021-2025 | Mo.Ma Ultra, Corevalve Evolut R, Onyx Frontier |
| Microvention, INC. | $400.00 | 2020 | |
| Penumbra, INC. | $394.84 | 2019-2025 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $390.65 | 2020-2021 | |
| Inari Medical, INC. | $381.88 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Veryan Medical Incorporated | $260.95 | 2021 | |
| Medtronic Vascular, INC. | $245.79 | 2019-2020 | |
| Surmodics, INC. | $182.14 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Thrombectomy System |
| Stryker Corporation | $179.23 | 2025 | Limflow System, Artix Mt |
| Angiodynamics, INC. | $153.42 | 2021-2024 | Alphavac, Auryon Laser System 100-120 Vac |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $149.34 | 2023 | Interventional Angiography System |
| Procyrion, INC. | $137.64 | 2024-2025 | Aortix System |
| Cardiva Medical, INC. | $131.39 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Contego Medical, INC | $112.76 | 2025 | |
| Silk Road Medical, INC. | $112.37 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Avinger INC. | $101.41 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $97.10 | 2019 | |
| Cvrx, INC. | $44.25 | 2024-2025 | Barostim Neo System |
| Philips North America LLC | $40.05 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $39.29 | 2019-2020 | |
| Biotronik INC. | $39.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.60 | 2024-2025 | Camzyos |
| Cagent Vascular INC | $29.60 | 2025 | Serrantor |
| Pfizer INC. | $29.40 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $23.15 | 2022 | |
| W. L. Gore & Associates, INC. | $20.00 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $17.72 | 2024 | Arcalyst |
| Teleflex LLC | $15.15 | 2022 | |
| Reflow Medical INC | $12.98 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $12.72 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Katopodis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.